Cigna Group (CI) earnings date, results and what the price requires
NYSE · SEC CIK 0001739940 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 30, 2026 | $71.67B | $1.66B | $6.29 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $68.49B | $1.65B | $6.26 | Filing |
| Dec 31, 2025 | Feb 5, 2026 | $72.47B | — | $4.64 | Filing |
| Sep 30, 2025 | Oct 30, 2025 | $69.75B | — | $6.98 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $67.18B | $1.53B | $5.71 | Filing |
| Mar 31, 2025 | May 2, 2025 | $65.50B | $1.32B | $4.85 | Filing |
| Dec 31, 2024 | Jan 30, 2025 | $65.65B | — | $5.01 | Filing |
| Sep 30, 2024 | Oct 31, 2024 | $63.69B | — | $2.63 | Filing |
What would Cigna Group have to report for its valuation to change?
At $298.81, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 1.1% a year, to $25.54. On that path the next quarter needs diluted EPS near $7.06, against $6.98 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 1.1% | 1.1% |
| EPS needed in final year | $25.54 | $25.54 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CI goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.